Malignant hypertension: current challenges, prevention strategies, and future perspectives
IntroductionBased on office blood pressure (BP) values, hypertension is categorized into three stages: stage 1 (140–159/90–99 mmHg), stage 2 (160–179/100–109 mmHg), and stage 3 (≥180/≥110 mmHg). Malignant hypertension (MHT) is characterized by extreme BP elevation (systolic blood pressure above 200 ...
Saved in:
| Main Authors: | Abate Wondesen Tsige, Siraye Genzeb Ayele |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1409212/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monkeypox: Prevention Strategies and Challenges: Updated Review
by: Abate Wondesen Tsige, et al.
Published: (2025-04-01) -
Malignant hyperthermia: current approaches to prevention and treatment
by: E. S. Kim, et al.
Published: (2017-09-01) -
Acetylsalicylic acid in primary prevention among patients with arterial hypertension
by: A. V. Melekhov, et al.
Published: (2013-10-01) -
Severe visual loss from concurrent fulminant idiopathic intracranial hypertension and malignant arterial hypertension: Prompt suspicion matters
by: Bashaer Aldhahwani, et al.
Published: (2024-12-01) -
MALIGNANT HYPERTENSION WITH PREDOMINANT KIDNEY DAMAGE
by: N. D. Lapochkina, et al.
Published: (2018-05-01)